In summary, our findings indicate that, despite the morphological similarities between canine and its human counterpart, it appears that MDM2 amplification is not a defining feature of canine liposarcoma, although it may occur in a minority of cases, and MDM2 protein expression could potentially contribute to its oncogenic processes. This evidence concerns the gene MDM2 and liposarcoma.